Genomed Spolka Akcyjna Logo

Genomed Spolka Akcyjna

Offers molecular diagnostics and DNA sequencing for medical and scientific research markets.

GEN | WAR

Overview

Corporate Details

ISIN(s):
PLGNOMD00024 (+3 more)
LEI:
259400MZZJNF1JFWAG26
Country:
Poland
Address:
Warszawa Ponczowa 12, 02-971 Warszawa
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Genomed S.A. is a biotechnology company specializing in molecular diagnostics and genetic research. It offers a range of services including DNA and RNA sequencing, analysis, and synthesis, primarily for the medical and scientific research markets in Poland and Europe. The company utilizes Next Generation Sequencing (NGS) technology to perform comprehensive genetic diagnostics, including the analysis of mutations responsible for thousands of congenital diseases and prenatal testing. A key strategic focus for Genomed is the advancement of personalized medicine through the introduction of genomic prevention into medical practice, with the long-term objective of creating a gene therapy clinic.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-13 18:18
Notice of Dividend Amount
Rekomendacja dotycząca podziału zysku Spółki za rok 2024 - Content (PL)
Polish 617 bytes
2024-04-15 14:45
Director's Dealing
Sprzedaż_G.Gromada
Polish 202.6 KB
2024-04-15 14:45
Director's Dealing
Powiadomienie o transakcjach na akcjach Spółki - Content (PL)
Polish 425 bytes
2024-04-12 13:38
Director's Dealing
Powiadomienie_Kupno-SPr
Polish 485.9 KB
2024-04-12 13:38
Director's Dealing
Powiadomienie o transakcjach na akcjach Spółki - Content (PL)
Polish 532 bytes
2024-01-05 12:08
Director's Dealing
Diagnostyka_Sprzedaż
Polish 5.2 KB
2024-01-05 12:08
Director's Dealing
Powiadomienie o transakcjach na akcjach Spółki - Content (PL)
Polish 414 bytes
2023-12-27 13:24
Director's Dealing
Diagnostyka_27DEC_2023
Polish 5.8 KB
2023-12-27 13:24
Director's Dealing
Powiadomienie o transakcjach na akcjach Spółki - Content (PL)
Polish 379 bytes
2023-12-27 11:10
Director's Dealing
ABC_23Dec2023
Polish 4.3 KB
2023-12-27 11:10
Director's Dealing
Powiadomienie o transakcjach na akcjach Spółki - Content (PL)
Polish 463 bytes
2023-12-21 16:20
Director's Dealing
Zgloszenie_Marek_Zagulski_23Dec_2023
Polish 4.3 KB
2023-12-21 16:20
Director's Dealing
Powiadomienie o transakcjach na akcjach Spółki - Content (PL)
Polish 416 bytes
2023-12-13 17:09
Director's Dealing
Diagnostyka_13Dec2023
Polish 5.5 KB
2023-12-13 17:09
Major Shareholding Notification
Powiadomienie o transakcjach na akcjach Spółki - Content (PL)
Polish 409 bytes

Automate Your Workflow. Get a real-time feed of all Genomed Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Genomed Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Genomed Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland
ACHI
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden
ACTI
Aladdin Healthcare Technologies SE Logo
Develops AI for drug discovery and diagnostics targeting age-related diseases.
Germany
NMI
Alteogen Inc. Logo
Biotech firm developing next-gen ADCs and biobetters with proprietary platform technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops small-molecule drug therapies for Alzheimer's, pain, and cognitive dysfunction.
Sweden
ALZCUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.